Daniel brings broad life sciences experience across corporate development and strategy, financing, and company building to Locust Walk. With the firm, he has worked on private financing, sell-side, buy-side, IPO advisory, and strategy consulting engagements for life sciences clients as well as company creation for Locust Walk Founded companies. Daniel brings deep experience in oncology/immunology, neurology, and regenerative medicine therapeutic areas with a special focus on advanced modalities including gene and cell therapies.
Prior to Locust Walk, Daniel was a team leader at Health Advances, a global healthcare management and strategy consulting firm, where he led projects with biopharmaceutical, medical technology, and private equity clients. His work encompassed multiple strategy engagement types across a range of companies from startups to large biopharma, with significant functional experience in portfolio and transaction strategy, asset and M&A due diligence, and asset forecasting, and valuation.
Daniel holds an MS in Biotechnology and a BS in Biology and Business from Brandeis University. He enjoys skiing, hiking, cooking, and weightlifting in his free time and co-organizes an LGBTQ beer club in Boston.
He is a FINRA registered representative and holds his Series 79 and 63 licenses.